Kan Yang

Kan Yang

Auto-generated profile, based on publicly available information

Kan Yang

Department of Developmental and Behavioral Pediatric and Child Primary Care, Brain and Behavioral Research Unit of Shanghai Institute for Pediatric Research and MOE-Shanghai Key Laboratory for Children’s Environmental Health of Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2023 in Neural Regeneration Research
Verified
Journal Article
Open access
KYKan Yang
Kan Yang
YYYuqing Yan
Yuqing Yan
AYAnni Yu
Anni Yu
RZRu Zhang
Ru Zhang
YZYuefang Zhang
Yuefang Zhang
FLFei Li
Fei Li
Mitochondria are critical cellular energy resources and are central to the life of the neuron. Mitophagy selectively clears damaged or dysfunctional mitochondria through autophagic machinery to maintain mitochondrial quality control and homeostasis. Mature neurons are postmitotic and consume substantial energy, thus require highly efficient mitophagy pathways to turn over damaged or dysfunctional mitochondria. Recent evidence indicates that mitophagy is pivotal to the pathogenesis of neurological diseases. However, more work is needed to study mitophagy pathway components as potential therapeutic targets. In this review, we briefly discuss the characteristics of nonselective autophagy and selective autophagy, including ERphagy, aggrephagy, and mitophagy. We then introduce the mechanisms of Parkin-dependent and Parkin-independent mitophagy pathways under physiological conditions. Next, we summarize the diverse repertoire of mitochondrial membrane receptors and phospholipids that mediate mitophagy. Importantly, we review the critical role of mitophagy in the pathogenesis of neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Last, we discuss recent studies considering mitophagy as a potential therapeutic target for treating neurodegenerative diseases. Together, our review may provide novel views to better understand the roles of mitophagy in neurodegenerative disease pathogenesis.

25 August 2017 in Autophagy
Verified
Journal Article
Open access
KYKan Yang
Kan Yang
BYBin Yu
Bin Yu
CCCheng Cheng
Cheng Cheng
TCTianlin Cheng
Tianlin Cheng
BYBo Yuan
Bo Yuan
YZYuxun Zhou
Yuxun Zhou
In addition to the canonical role in protein homeostasis, autophagy has recently been found to be involved in axonal dystrophy and neurodegeneration. Whether autophagy may also be involved in neural development remains largely unclear. Here we report that Mir505-3p is a crucial regulator for axonal elongation and branching in vitro and in vivo, through modulating autophagy in neurons. We identify that the key target gene of Mir505-3p in neurons is Atg12, encoding ATG12 (autophagy-related 12) which is an essential component of the autophagy machinery during the initiation and expansion steps of autophagosome formation. Importantly, axonal development is compromised in brains of mir505 knockout mice, in which autophagy signaling and formation of autophagosomes are consistently enhanced. These results define Mir505-3p-ATG12 as a vital signaling cascade for axonal development via the autophagy pathway, further suggesting the critical role of autophagy in neural development.

18 February 2026 in Nature
Verified
Journal Article
Open access
PDF file
KYKan Yang
Kan Yang
WLWei-Ke Li
Wei-Ke Li
YGYi-Xiao Geng
Yi-Xiao Geng
SZShu-Qian Zhang
Shu-Qian Zhang
SWShi-Hao Wu
Shi-Hao Wu
ZQZilong Qiu
Zilong Qiu
Neurodevelopmental disorders that arise from de novo mutations in chromatin-remodelling genes lack targeted treatments. Snijders Blok–Campeau syndrome (SNIBCPS)1, which is caused by pathogenic variants in CHD3, manifests with intellectual disability, autistic-like behaviours and motor deficits2. Whether somatic gene correction can reverse such phenotypes in vivo remains unknown. Here we show that modelling the recurrent CHD3 variant p.R1025W in a humanized mouse model (Chd3hR1025W/+) recapitulates key features of SNIBCPS, including reduced CHD3 protein levels and abnormalities in social communication, cognition and motor coordination. We engineered a TadA-embedded adenine base editor (TeABE) and delivered it brain-wide using a dual adeno-associated virus (AAV) system and achieved efficient on-target A•T-to-G•C correction across multiple cortical and hippocampal regions with minimal bystander activity. This intervention restored CHD3 levels and ameliorated behavioural abnormalities in vivo. Furthermore, intrathecal dual AAV delivery in nonhuman primates resulted in widespread neuronal transduction and efficient TeABE reconstitution, a result that supports its translational feasibility. These findings establish in vivo base editing as a viable therapeutic approach for CHD3-related neurodevelopmental disease. More broadly, they demonstrate that precise single-base correction in the postnatal brain can restore protein dosage and function, thereby offering a framework for the treatment of monogenic neurodevelopmental disorders.

25 September 2024 in STAR Protocols
Verified
Journal Article
Open access
KYKan Yang
Kan Yang
TLTianshu Li
Tianshu Li
YGYixiao Geng
Yixiao Geng
RZRu Zhang
Ru Zhang
ZXZhankui Xu
Zhankui Xu
FLFei Li
Fei Li
Here, we present a protocol for neonatal intracerebroventricular (ICV) delivery of adeno-associated viral vectors (AAVs), achieving gene therapy for a Rett syndrome mouse model. We describe steps for preparing mouse lines, replacing foster mothers, sex typing, and genotyping. We then detail procedures for ICV delivery and validation through immunofluorescent and immunoblot techniques. This protocol is also applicable to preclinical gene therapy research that targets the neonatal mouse brain for other neurodevelopmental disorders. For complete details on the use and execution of this protocol, please refer to Yang et al.1.

31 March 2026 in Biological Psychiatry
Verified
Journal Article
Closed access
KYKan Yang
Kan Yang
YGYixiao Geng
Yixiao Geng
WZWei Zhou
Wei Zhou
LZLingli Zhang
Lingli Zhang
ZXZhankui Xu
Zhankui Xu
ZQZilong Qiu
Zilong Qiu

28 January 2025 in Research Square
Verified
Preprint
Open access
PDF file
KYKan Yang
Kan Yang
Snijders Blok-Campeau Syndrome (SNIBCPS) is a rare neurodevelopmental disorder caused by mutations in the CHD3 gene. Here, we report a de novo single-nucleotide variant (c.C3073T, p.R1025W) in CHD3 identified in a child with SNIBCPS, which leads to accelerated degradation of the CHD3 protein. Using a Chd3 R1025W/+ knock-in mouse model, we observed impaired vocalization, cognition, and autism-like behaviors. To address these deficits, we developed an improved TadA-embedded adenine base editor (TeABE) and delivered into the mouse brain via Adeno-associated virus (AAV). Base editing in vivo significantly restored CHD3 protein levels in the mouse brain and ameliorated various behavioral abnormalities. Furthermore, we validated the AAV-mediated delivery efficacy of TeABE in nonhuman primate, highlighting its translational potential. These findings establish in vivo base editing as a promising therapeutic strategy for SNIBCPS and pave the way for clinical applications targeting brain disorders.